Skip to: site menu | section menu | main content
Fortnightly Lunch Time Clinical Conference
All talks will be held on Tuesday @ 1.00 - 2.00 PM at Seminar Room, 2nd Floor, Island Hospital. All doctors are welcome. Kindly call Tel: (604) 228 8222 and speak to Ms. Mei (ext. 5043) or Ms. Mimi Tay (ext. 5333) to confirm attendance by Saturday before the respective lectures. Lunch will be served from 12.30 PM to 1.45 PM
2 April 2008
-
7 April 2008
It is well established that aggressive risk factor modification results in improved cardiovascular disease (CVD) outcomes in both primary and secondary settings. The newest guidelines for treating people with coronary artery disease (CAD) suggest benefit from statin-induced LDL cholesterol lowering regardless of baseline LDL cholesterol level. These guidelines were based on recent clinical trials that showed statistically significant statin-induced relative risk reductions (RRR) in cardiovascular events. Especially patients in the intermediate to high risk groups will benefit from aggressive risk factor modifications. Patients with type 2 diabetes mellitus for example, have a much higher baseline risk for cardiovascular events. As type 2 diabetes and hypertension commonly coexist, achievin recommended targets for diabetes, hypertension, and CVD requires aggressive management. We are fortunate in 2008 to have very effective medications to target two of the most prevalent risk factors: BP and LDL cholesterol effectively. Global risk reduction with aggresive low-density lipoprotein reduction and through the additional normalization of glucose levels and blood pressure can help to reduce absolute risk in this and other very high-risk populations. In this lecture I will discuss current treatment algorithms and ways to overcome the difficulties in achieving BP and cholesterol targets.
8 April 2008
Thrombocytopaenia is a common haematology problem encountered by primary care physicians and specialist alike. It forms a diagnostic and therapeutic dilemma especially when a patient has a very low platelet count or is planned for an invasive procedure. The diagnostic workup and management of these patients remains a problem for many doctors.
In my talk I shall attempt to give an overview of the aetiology of thrombocytopaenia and the clues which leads to a diagnosis as well as discuss the management of the common disorders causing thrombocytopaenia with emphasis on management of immune thrombocytopaenia purpura (ITP).
22 April 2008
-
6 May 2008
-
20 May 2008
-
3 June 2008
Mr TJ Wong will discuss cases of early breast cancer from his file. Their clinical diagnoses using breast ultrasound / mammography will be highlighted. The significance of clustered microcalcification in early breast cancer and the use of hook wire localization and excision will be shown. The pathology of ductal carcinoma and lobular carcinoma in situ be reviewed. The significance of estrogen receptors, progesterone receptors and C-erB2 receptors status will be explained.
Wide excision and axillary clearance is the usual surgical operation followed by radiotherapy ± chemotherapy for early breast cancer.
17 June 2008
-